ERBB2 and breast carcinoma: For example, tucatinib (NCT03054363) is combined with palbociclib (a drug used to treat advanced breast cancer) and letrozole (aromatase inhibitor) used for treating hormone-receptor-positive and HER2-positive metastatic breast cancer patients.